CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 523 enrolled
Drug / intervention
Argosdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06085131
NCT06085131N/ACompleted
CompareCT.gov

Accuracy of the New Barrett TAL Formula With the Argos Measurements: A Multicenter Prospective Study

Shammas Eye Medical Center·observational·Posted Oct 16, 2023·Updated May 27, 2026

In Brief

An observational study evaluating Argos for Cataract. Completed, enrolled 523 participants across 6 sites.

Detailed Summary

This study is a prospective, multi-site, multi-surgeon, observational study of refractive accuracy with the Argos using BTAL after successful cataract surgery. Subjects will be assessed pre-operatively, operatively and at 5-8 weeks postoperatively. Clinical evaluations will include measurement of visual acuity, manifest refraction, and preoperative biometry.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
202420252026
First PostedOct 16, 2023
Enrollment StartOct 31, 2023
Primary CompletionJan 29, 2025
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 2.7 years ago

Interventions

Argosdevice

Argos Biometer